Affiliations: [a] Department of Chemistry, Dezful Branch, Islamic Azad University, Dezful, Iran
| [b] Department of Chemistry, Payame Noor University, Tehran, Iran
| [c] Department of Pharmaceutics, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Correspondence:
[*]
Corresponding authors. Halimeh Rajabzadeh, Department of Chemistry, Dezful Branch, Islamic Azad University, Dezful, Iran. r.rajabzadeh77@gmail.com ORCID numbers: 0000-0001-6649-9009 and Maryam Abbasi, Department of Chemistry, Payame Noor University, Tehran, Iran. m.abbasi.res@gmail.com ORCID numbers: 0000-0002-5105-5381.
Abstract: Existence of iron (Fe) is important for cells of living systems; however, its level of magnitude for those patients infected by novel coronavirus disease (COVID-19) is still a challenging issue. Therefore, such mechanism of function was investigated in this work by assistance of thiofavipiravir (TFav) compounds generated by the well-known favipiravir (Fav) drug used for medication of COVID-19 patents. To this aim, sulfur-substitutions of oxygen atoms of Fav were done and the obtained parent structures were prepared for participating in Fe-chelation function. The results indicated that the modes were suitable for running such Fe-chelation processes, in which favorability and strength the models were ranged in this order: 1O2S-Fe > 1S2S-Fe > 1O2O-Fe > 1S2O-Fe. As a consequence, such idea of sulfur-substitution of Fav drug for more appropriate favorability of participating in Fe-chelation process was sensed by results of this work proposing 1O2S compound as the most favorable one for doing the function. Hence, information about capability of TFav compounds for participating in Fe-chelation processes were provided in this work regarding the challenging issue of Fe-chelation in medication of COVID-19 patients. All results of this work were obtained by performing computations using the density functional theory (DFT) approach
